Transnational Cannabis Ltd. (TRCNF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerTransnational Cannabis Ltd. (TRCNF) trades at $0.00004. Transnational Cannabis Ltd. is a Canadian-headquartered company operating in the global cannabis sector, holding licenses for cultivation, production, supply, storage, import, export, and distribution of cannabis and its derivatives. Sector: Healthcare.
Price as of · Last analyzed: Jun 14, 2026Analyst Coverage for TRCNF: TRCNF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Transnational Cannabis Ltd. (TRCNF) Healthcare & Pipeline Overview
Transnational Cannabis Ltd. is a Canadian-headquartered company operating in the global cannabis sector, holding licenses for cultivation, production, supply, storage, import, export, and distribution of cannabis and its derivatives. The company focuses on both domestic and international markets, including medical cannabis products, and leverages strategic alliances to expand its operational footprint and product reach.
What Is the Investment Thesis for TRCNF?
Transnational Cannabis Ltd. operates with a comprehensive licensing framework enabling cultivation, production, and international distribution of cannabis and derivatives, positioning it to capitalize on the expanding global cannabis market. The company's strategic alliances with partners like Auxly Cannabis Group Inc. and Authentic Brands Group are crucial for enhancing product development, market access, and distribution capabilities, driving potential revenue growth in diverse segments. Its involvement in the procurement and distribution of medical cannabis products aligns with increasing global demand for therapeutic applications, representing a significant value driver. However, the company's listing on the OTC Other tier presents inherent risks, including potentially limited regulatory oversight and reduced liquidity, which could impact investor sentiment and trading efficiency. Furthermore, the cannabis industry is subject to evolving regulatory landscapes across different jurisdictions, posing ongoing compliance challenges and potential operational hurdles. Investors should monitor the company's ability to leverage its international licenses and strategic partnerships to expand market share, particularly within the medical cannabis segment, while carefully assessing the implications of its OTC market status and the dynamic regulatory environment.
Based on FMP financials and quantitative analysis
TRCNF Key Highlights
Market Capitalization: $0.00 billion, indicating a micro-cap or non-reporting status within the public markets.
- Beta: -100.16, suggesting an extremely high inverse correlation and volatility relative to the broader market.
- Dividend Policy: No dividend yield, as the company does not currently distribute dividends to shareholders.
- Operational Scope: Possesses comprehensive licenses for cultivation, production, supply, storage, import, export, and transportation of cannabis and its derivative products.
- Strategic Partnerships: Engages in key alliances with entities such as Auxly Cannabis Group Inc. and Authentic Brands Group, aiming to bolster market access and product distribution.
Who Are TRCNF's Competitors?
TRCNF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TRCNF's Key Strengths?
Comprehensive licensing for cultivation, production, and international trade of cannabis.
- Established strategic alliances with multiple key partners like Auxly Cannabis Group Inc.
- Focus on both domestic Canadian and international cannabis markets.
- Involvement in the procurement and distribution of medical cannabis products.
What Are TRCNF's Weaknesses?
Market capitalization of $0.00B, indicating a very small scale or non-reporting status.
- Extremely high negative Beta (-100.16), suggesting high volatility and inverse market correlation.
- OTC Other tier listing, implying potentially limited regulatory oversight and transparency.
- Unknown disclosure status on the OTC market, hindering investor access to information.
What Are the Key Risks for TRCNF?
Financial-distress signal — its Altman Z-Score of -6.51 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory complexities and evolving legal frameworks in the global cannabis industry.
- High operational risk and limited liquidity associated with its OTC Other tier listing.
- Intense competition from larger, better-capitalized cannabis companies.
- Challenges in maintaining and expanding strategic alliances in a dynamic market.
- disclosure status, potentially limiting investor access to critical financial and operational information.
What Threats Does TRCNF Face?
- Evolving and complex regulatory landscapes across different international jurisdictions.
- Intense competition from larger, better-capitalized cannabis operators.
- Risks associated with OTC Other tier trading, including liquidity and investor confidence.
- Potential for adverse changes in public perception or government policy regarding cannabis.
What Are TRCNF's Competitive Advantages?
- Comprehensive licensing for a wide range of cannabis activities, including cultivation, production, and international trade.
- Established strategic alliances with multiple key industry partners, enhancing market reach and capabilities.
- International operational scope with a focus on global cannabis markets.
- Specialized expertise in the procurement and distribution of medical cannabis products.
What Does TRCNF Do?
Transnational Cannabis Ltd., founded in 2006 and headquartered in Vancouver, Canada, has established itself as a multifaceted operator within the global cannabis sector. Initially known as ICC International Cannabis Corp., the company underwent a strategic rebranding in February 2020, adopting its current name to better reflect its expansive international ambitions and operational scope. Through its various subsidiaries, Transnational Cannabis holds a comprehensive suite of licenses that permit a wide array of activities crucial to the cannabis supply chain. These licenses enable the company to engage in the cultivation, production, supply, storage, import, export, and transportation of cannabis and its derivative products. This broad operational capability allows Transnational Cannabis to control multiple stages of its product lifecycle, from raw material to finished goods, ensuring quality and compliance across its value chain. A significant component of its business model involves the procurement and distribution of medical cannabis products and various cannabis derivatives, catering to the growing global demand for therapeutic applications of cannabis. The company's strategic reach extends beyond its domestic Canadian operations, with a stated focus on international markets, positioning it to capitalize on the expanding legalization and acceptance of cannabis worldwide. To bolster its market presence and operational efficiency, Transnational Cannabis has forged strategic alliances with several key partners. These include Green Tree International Inc., Auxly Cannabis Group Inc., Affinity Alpha Unit, Authentic Brands Group, and Biotii Technologies Corp. These partnerships are instrumental in enhancing the company's capabilities in areas such as product development, distribution networks, and market access, providing a competitive edge in a rapidly evolving industry. By combining its licensed operational framework with strategic collaborations, Transnational Cannabis aims to solidify its position as a significant player in both the Canadian and international cannabis landscapes.
What Products and Services Does TRCNF Offer?
- Cultivate cannabis plants under licensed conditions.
- Produce various cannabis products and derivatives.
- Supply cannabis and its derivatives to authorized markets.
- Store cannabis products securely and compliantly.
- Import and export cannabis products across international borders.
- Transport cannabis and its derivatives within regulatory frameworks.
- Procure medical cannabis products from various sources.
- Distribute medical cannabis products and derivatives to designated channels.
How Does TRCNF Make Money?
- Generates revenue from the sale of cultivated and produced cannabis products.
- Earns income through the distribution of medical cannabis and its derivatives.
- Benefits from international trade activities, including import and export of cannabis products.
- Creates value through strategic alliances that enhance market access and product development capabilities.
What Industry Does TRCNF Operate In?
Transnational Cannabis Ltd. operates within the dynamic and rapidly evolving global cannabis sector, specifically categorized under Drug Manufacturers - Specialty & Generic. This industry is characterized by significant regulatory complexities and varying legal frameworks across jurisdictions, which present both challenges and substantial growth opportunities. A key market trend is the ongoing expansion of legal cannabis markets worldwide, driven by increasing medical acceptance and recreational legalization initiatives. This trend creates a fertile ground for companies with comprehensive licensing and international distribution capabilities. The competitive landscape is fragmented, featuring numerous players ranging from large multi-state/multi-country operators to smaller, specialized cultivators and distributors. Transnational Cannabis positions itself through its broad licensing for cultivation, production, and international trade, coupled with a focus on medical cannabis products. Its strategic alliances are critical in navigating this competitive environment, enabling broader market reach and diversified product offerings within a sector projected for substantial growth as regulatory barriers continue to ease in various regions.
Who Are TRCNF's Key Customers?
- Licensed distributors and retailers in domestic and international cannabis markets.
- Medical patients accessing products through authorized medical cannabis channels.
- Strategic partners for collaborative product development and distribution initiatives.
- Wholesale buyers of cannabis and various derivative products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on assets is -86.5%, showing how much profit it generates from its asset base. A current ratio of 1.40 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
Transnational Cannabis Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO David Shpilt. TRCNF has traded publicly since 2018.
Financial Health
Transnational Cannabis Ltd.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.51 places it in the distress zone, a signal of elevated financial risk.
TRCNF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
TRCNF Latest News
No recent news available for TRCNF.
TRCNF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TRCNF.
Price Targets
Wall Street price target analysis for TRCNF.
TRCNF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for TRCNF; grades run from A+ (80-100) to F (below 30).
TRCNF OTC Market Information
Transnational Cannabis Ltd. trades on the OTC Other tier, which represents the lowest and most speculative segment of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial reporting, corporate governance, and minimum share prices, companies on the OTC Other tier have minimal to no reporting requirements with the SEC. This tier is typically for companies that do not meet the standards for OTCQX or OTCQB, or choose not to report. It often involves companies with limited public information, making due diligence more challenging for investors.
- OTC Tier: OTC Other
- Limited regulatory oversight and financial transparency due to minimal reporting requirements.
- Significantly lower liquidity, leading to wider bid-ask spreads and difficulty in trading shares.
- Increased susceptibility to market manipulation and fraudulent activities.
- Difficulty in obtaining reliable and timely financial information for informed decision-making.
- Higher volatility and potential for significant price fluctuations due to low trading volume.
- Verify the company's current operational status and active licenses in all jurisdictions.
- Scrutinize any available financial statements for revenue, profitability, and cash flow trends.
- Research the background and track record of management and board members.
- Investigate any news or regulatory filings from Canadian authorities (as HQ is Canada).
- Assess the legitimacy and activity of its stated strategic alliances and partnerships.
- Evaluate the competitive landscape and the company's specific niche within the cannabis market.
- Understand the specific regulatory environment in all jurisdictions where it operates.
- Headquartered in Vancouver, Canada, a country with federally legal cannabis.
- Explicitly states holding necessary licenses for comprehensive cannabis activities.
- Has established strategic alliances with named partners (e.g., Auxly Cannabis Group Inc.).
- Founded in 2006, indicating a long operational history, albeit with a name change.
- Operates in a regulated industry (healthcare/drug manufacturers).
Transnational Cannabis Ltd. Healthcare Stock: Key Questions Answered
What does Transnational Cannabis Ltd. do?
Transnational Cannabis Ltd. operates across the entire cannabis value chain, leveraging its comprehensive licenses to cultivate, produce, supply, store, import, export, and transport cannabis and its derivative products.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The company's disclosure status on the OTC market is explicitly stated as 'Unknown'.